Roche Holding, CH0012032048

Roche Holding stock heads into the open after a September 23 drop

Published on 09/25/2026 at 06:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Roche Holding stock traded at CHF 365.85 on SIX, with a CHF 361.00 to CHF 368.20 range. A Roche drug discovery deal worth up to USD 2 billion was reported that day.

Automatisches Diagnostik-Laborgerät mit Touchscreen-Oberfläche im klinischen Labor
Roche Holding AG CH0012032048 – Diagnostik-Analysegerät verarbeitet biologische Proben im modernen klinischen Labor, Illustration mit AI erstellt.

Roche Holding stock closed at CHF 365.85 on SIX on September 23, 2026, down 0.48 percent. The shares traded between CHF 361.00 and CHF 368.20 during the session.

September 23, 2026 in numbers

Roche Holding AG (ISIN CH0012032048) closed at CHF 365.85 on SIX on September 23, 2026, compared with a prior close of CHF 364.10. The session range was CHF 361.00 to CHF 368.20, giving investors a CHF 7.20 spread between the low and high.

As Reuters reported on September 24, 2026, Roche and Atavistik Bio signed a drug discovery deal potentially worth nearly USD 2 billion, including milestone payments, for oral treatments targeting cardiovascular, kidney and metabolic diseases.

Today, September 25, 2026

Roche shares enter the pre-market news cycle with the Atavistik Bio agreement as the latest company-specific development. The Swiss market context includes the SMI at 13,899.05 at the close on September 24, 2026, according to a dated Swiss market report.

Disclaimer...

en | CH0012032048 | ROCHE HOLDING | boerse | 70180852 | bgmi